# Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

**Authors:** Guang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, Xiao Zhang, Lun-Jie Yan, Rui-Zhe Li, Zi-Niu Ding, Si-Yu Tan, Dong-Xu Wang, Bao-wen Tian, Yu-Chuan Yan, Zhao-Ru Dong, Jian-Guo Hong, Tao Li

PMC · DOI: 10.1186/s12935-024-03399-x · 2024-07-23

## Full-text entities

- **Genes:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938] {aka HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, miPEP-52}, BRF2 (BRF2 general transcription factor IIIB subunit) [NCBI Gene 55290] {aka BRFU, TFIIIB50}, STK11 (serine/threonine kinase 11) [NCBI Gene 6794] {aka LKB1, PJS, hLKB1}
- **Diseases:** HCC (MESH:D006528)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11264463/full.md

---
Source: https://tomesphere.com/paper/PMC11264463